Trials / Completed
CompletedNCT00650286
Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg
Single-Dose Food In Vivo Bioequivalence Study of Modafinil Tablets (200 mg; Mylan) to Provigil® Tablets (200 mg; Cephalon) in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mylan Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg) dose administration under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modafinil Tablets 200 mg | 200mg, single dose fed |
| DRUG | Provigil® Tablets 200 mg | 200mg, single dose fed |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2002-10-01
- Completion
- 2002-10-01
- First posted
- 2008-04-01
- Last updated
- 2024-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00650286. Inclusion in this directory is not an endorsement.